Unknown

Dataset Information

0

Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions.


ABSTRACT: We performed a real-life analysis of clinical and laboratory parameters, in orally treated T2DM patients aiming at identifying predictors of insulin treatment initiation. Overall, 366955 patients (55.8% males, age 65?±?11 years, diabetes duration 7?±?8 years) were followed up between 2004 and 2011. Each patient was analyzed step-by-step until either eventually starting insulin treatment or getting to the end of the follow-up period. Patients switching to insulin showed a worse global risk profile, longer disease duration (10?±?9 years vs. 6?±?7 years, respectively; p < 0.001), higher HbA1c (8.0?±?1.6% vs. 7.2?±?1.5%, respectively; p < 0.001), higher triglycerides, a greater prevalence of arterial hypertension, antihypertensive, lipid-lowering and aspirin treatment, a higher rate of nonproliferative/proliferative retinopathy, and a nearly 4 times lower prevalence of the "diet alone." They also showed a higher prevalence of subjects with eGFR?

SUBMITTER: Gentile S 

PROVIDER: S-EPMC6169213 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions.

Gentile Sandro S   Strollo Felice F   Viazzi Francesca F   Russo Giuseppina G   Piscitelli Pamela P   Ceriello Antonio A   Giorda Carlo C   Guida Piero P   Fioretto Paola P   Pontremoli Roberto R   De Cosmo Salvatore S   The Amd-Annals Study Group  

Journal of diabetes research 20180919


We performed a real-life analysis of clinical and laboratory parameters, in orally treated T2DM patients aiming at identifying predictors of insulin treatment initiation. Overall, 366955 patients (55.8% males, age 65 ± 11 years, diabetes duration 7 ± 8 years) were followed up between 2004 and 2011. Each patient was analyzed step-by-step until either eventually starting insulin treatment or getting to the end of the follow-up period. Patients switching to insulin showed a worse global risk profil  ...[more]

Similar Datasets

| S-EPMC6348703 | biostudies-literature
| S-EPMC4746663 | biostudies-literature
| S-EPMC8655276 | biostudies-literature
| S-EPMC2775929 | biostudies-literature
| S-EPMC7573347 | biostudies-literature
| S-EPMC7189618 | biostudies-literature
| S-EPMC4213668 | biostudies-literature
2021-08-24 | GSE182618 | GEO
| S-EPMC6055847 | biostudies-other
| S-EPMC10460390 | biostudies-literature